Enabling MedTech Translation in Academia: Redefining Value Proposition with Updated Regulations

Area of Science:

• Biomedical Engineering
• Regulatory Science
• Medical Device Development

Background:

• Academic institutions increasingly focus on translating research into clinical applications.
• The European regulatory landscape for medical devices is shifting from the Medical Device Directive (MDD) to the Medical Device Regulation 2017/745 (MDR).
• The MDR introduces stricter requirements for scientific, technical, and clinical data, potentially creating regulatory uncertainty.

Purpose of the Study:

• To analyze the impact of the new European Medical Device Regulation (MDR) on academic translational research.
• To identify challenges and opportunities for academic medical device development under the MDR.
• To propose strategies for overcoming regulatory hurdles in academic translation.

Main Methods:

• Review of the European Medical Device Regulation 2017/745 (MDR) and its implications.
• Analysis of the transition from the Medical Device Directive (MDD) to the MDR.
• Examination of potential barriers and facilitators for academic translational activities.

Main Results:

• The MDR increases demands for comprehensive data, posing challenges to academic institutions.
• Regulatory bodies face capacity constraints, leading to potential delays and uncertainty in product certification.
• Academic translational activities are uniquely affected by the evolving regulatory environment.

Conclusions:

• Successful medical device translation from academia requires proactive strategies to navigate the MDR.
• Strong clinical partnerships, industrial collaborations, and entrepreneurial programs are crucial for overcoming regulatory barriers.
• These strategies can help academic institutions maintain their role in medical device innovation and development.